Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Nature Communications|June 15, 2024
Acoustic ejection mass spectrometry empowers ultra-fast protein biomarker quantificationBart Van Puyvelde, Christie L Hunter, Maxim Zhgamadze, et al.
AJNR. American Journal of Neuroradiology|September 28, 2019
Multinodular and Vacuolating Posterior Fossa Lesions of Unknown SignificanceA Lecler, J Bailleux, B Carsin, et al.
Nature Communications|May 8, 2026
CD38⁺ endothelial remodeling marks spatially patterned vasculopathy in rapidly advancing periodontitis and peri-implantitisQuinn T Easter, Khoa L A Huynh, Camila Schmidt Stolf, et al.
Transplantation Proceedings|June 4, 2013
Maribavir use in practice for cytomegalovirus infection in French transplantation centersS Alain, M Revest, D Veyer, et al.
International Journal of Cardiology|February 23, 2016
Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trialD Guijarro, M Lebrin, O Lairez, et al.
European Journal of Neurology|April 18, 2020
Advanced multiparametric magnetic resonance imaging of multinodular and vacuolating neuronal tumorA Lecler, V Broquet, J Bailleux, et al.
Journal of Internal Medicine|December 8, 2017
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemiaC Craddock, J Versluis, M Labopin, et al.
Leukemia|February 14, 2015
HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFMM Robin, R Porcher, L Adès, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2011
Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TCJ O Bay, A Cabrespine, C Faucher, et al.
Bone Marrow Transplantation|April 5, 2016
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)A Stamatoullas, P Brice, M S Gueye, et al.
Pageof 14